These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Proximal Occlusion in the Right Coronary Artery Involving the Atrial Branch as a Strong Predictor of New-Onset Atrial Fibrillation in Acute Myocardial Infarction. Shiba T, Kondo Y, Senoo K, Nakano M, Okubo K, Ishio N, Shikama N, Kobayashi Y. Int Heart J; 2019 Nov 30; 60(6):1308-1314. PubMed ID: 31666450 [Abstract] [Full Text] [Related]
24. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort. Huisman MV, Ma CS, Diener HC, Dubner SJ, Halperin JL, Rothman KJ, Teutsch C, Schoof N, Kleine E, Bartels DB, Lip GY, GLORIA-AF Investigators. Europace; 2016 Sep 30; 18(9):1308-18. PubMed ID: 27335063 [Abstract] [Full Text] [Related]
25. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study. Bang CN, Gislason GH, Greve AM, Bang CA, Lilja A, Torp-Pedersen C, Andersen PK, Køber L, Devereux RB, Wachtell K. J Am Heart Assoc; 2014 Jan 21; 3(1):e000382. PubMed ID: 24449803 [Abstract] [Full Text] [Related]
27. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Rene AG, Généreux P, Ezekowitz M, Kirtane AJ, Xu K, Mehran R, Brener SJ, Stone GW. Am J Cardiol; 2014 Jan 15; 113(2):236-42. PubMed ID: 24176066 [Abstract] [Full Text] [Related]
28. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation. Liang JJ, Elafros MA, Mullen MT, Muser D, Hayashi T, Enriquez A, Pathak RK, Zado ES, Santangeli P, Arkles JS, Schaller RD, Supple GE, Frankel DS, Garcia FC, Deo R, Lin D, Riley MP, Nazarian S, Dixit S, Marchlinski FE, Callans DJ. J Cardiovasc Electrophysiol; 2018 Jun 15; 29(6):823-832. PubMed ID: 29513397 [Abstract] [Full Text] [Related]
32. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial. Tangelder MJ, Frison L, Weaver D, Wilcox RG, Bylock A, Emanuelsson H, Held P, Oldgren J. Am Heart J; 2008 Feb 09; 155(2):382-7. PubMed ID: 18215612 [Abstract] [Full Text] [Related]
34. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, Fukunami M, Koretsune Y, Takeda H, Hori M, Osaka Acute Coronary Insufficiency Study (OACIS) Group. Am J Cardiol; 2003 Nov 15; 92(10):1150-4. PubMed ID: 14609587 [Abstract] [Full Text] [Related]
35. The risk of stroke after acute myocardial infarction in patients with and without atrial fibrillation: A nationwide cohort study. Chiang CH, Hung WT, Huang WC, Jheng YC, Lai WY, Lin YY, Lin TW, Lin KC, Cheng CC, Kuo FY. J Chin Med Assoc; 2021 Dec 01; 84(12):1126-1134. PubMed ID: 34898532 [Abstract] [Full Text] [Related]
36. Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry. Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Lu S, Bartels DB, Lip GYH, GLORIA-AF Investigators. Am Heart J; 2018 Apr 01; 198():55-63. PubMed ID: 29653649 [Abstract] [Full Text] [Related]